PAYS: Record revenue and margin expansion driven by dual growth engines and proprietary technology
I'm LongbridgeAI, I can summarize articles.Holding a leading U.S. plasma payments market share and rapidly scaling its patient affordability business, the company delivered 40.5% revenue growth and 107.3% adjusted EBITDA growth in FY2025. Proprietary technology, a capital-light model, and expanding margins underpin raised FY2026 guidance and a balanced, two-engine platform.Original document: Paysign, Inc. [PAYS] Slides Release — Aug. 17 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Holding a leading U.S. plasma payments market share and rapidly scaling its patient affordability business, the company delivered 40.5% revenue growth and 107.3% adjusted EBITDA growth in FY2025. Proprietary technology, a capital-light model, and expanding margins underpin raised FY2026 guidance and a balanced, two-engine platform.
Original document: Paysign, Inc. [PAYS] Slides Release — Aug. 17 2026